Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Research & Development (2010 - 2026)

Nomad Power Solutions (NMAD) posted Research & Development of $62250.0 for Q2 2026, up 19.44% on a QoQ basis from $52118.0 in Q4 2025, and up 2.64% year-over-year from $60648.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Research & Development (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Research & Development for 17 years, with the latest figure at $62250.0 in Q2 2026.

  • On a quarterly basis, Research & Development rose 2.64% year-over-year to $62250.0 in Q2 2026; TTM through Jun 2026 was $225712.0, a 58.85% decrease from a year earlier, with the FY2025 full-year figure at $254919.0, down 64.9% from the prior year.
  • Research & Development was $62250.0 for Q2 2026 at Nomad Power Solutions, up from $52118.0 in the prior quarter.
  • The five-year high for Research & Development was $458450.0 in Q1 2022, with the low at $34830.0 in Q4 2024.
  • Average Research & Development over 5 years is $193574.6, with a median of $149071.0 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Research & Development surged 172.96% in 2024, then sank 85.98% in 2025.
  • Over 5 years, Research & Development stood at $453620.0 in 2022, then slumped by 67.14% to $149071.0 in 2023, then sank by 76.64% to $34830.0 in 2024, then surged by 49.64% to $52118.0 in 2025, then climbed by 19.44% to $62250.0 in 2026.
  • The last three Research & Development figures came in at $62250.0 (Q2 2026), $52118.0 (Q4 2025), and $50696.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -486.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 202.02 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 62,250.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62,250.00
Dec 31, 2025 52,118.00
Sep 30, 2025 50,696.00
Jun 30, 2025 60,648.00
Mar 31, 2025 91,457.00
Dec 31, 2024 34,830.00
Sep 30, 2024 361,630.00
Jun 30, 2024 210,708.00
Mar 31, 2024 119,064.00
Dec 31, 2023 149,071.00
Sep 30, 2023 132,487.00
Jun 30, 2023 427,457.00
Mar 31, 2023 189,085.00
Dec 31, 2022 453,620.00
Sep 30, 2022 272,388.00
Jun 30, 2022 164,810.00
Mar 31, 2022 458,450.00
Dec 31, 2021 803,654.00
Sep 30, 2021 227,181.00
Jun 30, 2021 262,415.00